{"ticker": {"uuid": "ce0ab258-fd50-40fc-b717-6468d812c623", "symbol": "TRAX", "name": "First Tracks Biotherapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "First Tracks Biotherapeutics (TRAX) News Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwJBVV95cUxNbDJZcEdQN1VMWElpeEc5NExabExUaV9MNjEtQ1M3QnMzU2llOXlXVGlBTTZSVVpiM3l3cG5zRGhzZktOeVBVbHViSkRyeFhHNXM2WWNDaEU3S0tvUmxOOENJNXVRX2JuWEJBLUF6Z0dpWS1QLXlNLXRqaWNpMVBpTWh2Z2J6R3JLSkZDRlhrX0JXR3hKcUt4WFpfVUtPQ3k3a04wZko4Y1JGNFpCLXFMaE40MjJjR1ljSlNpaHZKUHF5NDAyTEcxTlo5SGlQNXp5dGo4X0I3Z2VkTDkxUUMzR3lJenlfenJ4QlFlUnJvRDkzYmNfUHB3UFV2eW43azVzZjlzVG5mSThmR3pZLWR6UmtyMmt6ZDNzeHVJcE83dw?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T04:56:01+00:00", "published_display": "13 Jul 2026 04:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $44", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNaUt6UFgyZkR3WDR3OFgxOWJvclFIYWlJMV9ILVJwR1FvdzV3X0VnU2JtMDFVWWlXU3JLREg0WmVIbmhiNjd4MkdLV3EwT2o4WFR4Q0pjaDFMcmhTUGgtVUw5dktsOTRzeFRoeXlWbUhQVDNYa1B2YVlhZDJkY0FadjdfSDZTdmprdE9pWHNTV3gtZjFtbWY4cGpjT3lkRzZ2MmcwRDJ4WXA5NElZRVhjRzBEVmM4SXc?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-10T16:36:12+00:00", "published_display": "10 Jul 2026 16:36", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9hM3JCNjBYQTdnVEhkZno5emZkTkt5Wk40TXNEVW5LM2VUR19rYkVpN2hZWGw0Uy1WZ29OR2RQUjZPN0hFYk9aaFQ0eV81QQ?oc=5", "source_name": "mexc.co", "published_at": "2026-07-10T14:18:03+00:00", "published_display": "10 Jul 2026 14:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics Inc. (TRAX) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE1YUmhkTHpNWl9CZE5BcHRYbEgtelJvbmllaWlucUF0V3Q2TDNpMnN5OGlwVmVMN0llaV9QaUlhNG81UkxnMkpXTm1SbHI5dw?oc=5", "source_name": "StocksToTrade", "published_at": "2026-07-10T00:43:00+00:00", "published_display": "10 Jul 2026 00:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (NASDAQ: TRAX) subleases 45,057 sq ft in San Diego", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQVWpuRmxJOWljekJKRTRvSmlLSVlTVUdoMFZDQ2RpSWtldzRtSzZ5aGhKYUp5QjYzRWxSaUdJTzR4dk9Pd1RjdzlFV1pKNVhrV3FlclZBM1ZUQzZOeEhkdnRIS2ljQ3FvM21RZzZFSXhUQUJ5dUh0cUQ1dTZWVnY5X1NIb1hQWnJha1hnYkFOSGI2YmVjVFlVZXhYNWJlQ1ViWTIwZHVqVlZENXBXSXpxTnUzbEtXbTMycWVPMkhR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rita Jain of First Tracks Biotherapeutics (TRAX) exercises RSUs, lifts holdings to 19,194 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQQXUwdVpSREZJY2JtaEFkQWtDUi00LTgtdWZGRHFxUEtacDBHbXFPaDdmMHZPanozRTNMQjFkTmNYdnpDaEk0bW9xTVhZSW56dFlyaGNIQ0hzRHlPUUpzWDRYLU91eVRCVm96a3dKQzhBa1k3dURqSUVDWlZxTEpJQ1RuOE1HUDg1YkFmcVh6RVgxbTVwUXVzYVZrd21VbnA3TlEtRWo3bFZjOWRSWUhNRDBDOWkzSkFSQW5IenFVazdlY1Iz?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (TRAX) director converts 6,030 RSUs into common stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOLXJ4eDFUVDcwMjdLVDg1elNsNU50WlZyUVZ6TWR6YjBrbHZ2dmV6ZXppRlczdXdtaGE0dzBBOUdDRmxkUGNfT2pWSG96ZG40RldDSHYyYjhGQWtoZTNnS19QTHNEYWhnSjR1V2NWVEMyZ1ctcVVBUEZ3dlVGVlVXMXVLb1l4djNxOGxrV2Q1V2d5NURURXJDSUxhamFRTzdJd0kwMFh3WEJZUGlscmhBNkUyNTgwdEo2ZUJkQWg4UWp1d2l3?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/first-tracks-biotherapeutics-announces-participation-201500599.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T20:15:00+00:00", "published_display": "21 May 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/first-tracks-biotherapeutics-announces-first-201500695.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T20:15:00+00:00", "published_display": "14 May 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://finance.yahoo.com/news/anaptys-announces-first-quarter-2026-201500897.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T20:15:00+00:00", "published_display": "12 May 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Piper Sandler Initiates Coverage on First Tracks Biotherapeutics With Overweight Rating, $54 Price Target", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/piper-sandler-initiates-coverage-first-121857533.html", "source_name": "MT Newswires", "published_at": "2026-05-04T12:18:57+00:00", "published_display": "04 May 2026 12:18", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "First Tracks Biotherapeutics (TRAX) Stock Trends and Sentiment 2026 $TRAX", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTFAtRFVUejdTMTA0anlfVThnUW10Rk5wZWVUSXZ6UmNkZUVkNFRwekx1ZHE2Y05FdVhuc1VjSmxhN095ZzRCYUFYX1FtZVZrRlk3QVZETVRWV3ZnNjdLRmFCX3pmblM3YXI3dFVrTUlISVFKRngxRVE?oc=5", "source_name": "MarketBeat", "published_at": "2026-04-21T16:08:34+00:00", "published_display": "21 Apr 2026 16:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (TRAX) Stock Forecast and Price Target 2026 $TRAX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5UTUtSME9MWWNreXFja0VtTHhySFdYMk1RSTNhVTBnWldqVFVkcmNESGp3akE2WEhrS01VbHlnT2JZZU5NRkV0TXJ0b2l4OUM1THQwT21hdjRXRmpQYnNJbVREQkRYZw?oc=5", "source_name": "MarketBeat", "published_at": "2026-04-21T15:42:34+00:00", "published_display": "21 Apr 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (TRAX) Stock Price, News & Analysis $TRAX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE90bzE4eUNTRExvenNKMTRWX2FNMVBvWmxGODJtdkpjSGthMXF2WnJjUWh6NmlpaXlLUE5tWFFTNTJZQlR6dXBJUlBMRWpkTDc5WVBNWXZ0SzBxUQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-04-21T14:18:23+00:00", "published_display": "21 Apr 2026 14:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (TRAX) Stock Chart and Price History 2026 $TRAX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE1XS3U0eWZlcUhYXzNHNU1tQ013SEt3Q0RfUlVld0F4MUo3QnhrdUlkUEwyaW1nc2MxSTZsV1ZsNzl1OTdqN0NYZnQ3SHk1TVo0X1JUZjltOFpVbnNzR29PRjVR?oc=5", "source_name": "MarketBeat", "published_at": "2026-04-21T14:16:10+00:00", "published_display": "21 Apr 2026 14:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics (ANAB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPWEhVM1c0S09lTUNwU2l0ZVFFS2VTY2FiUWJoNVp1MXFRV0JZZkxUZHZYR0FOMV84TUx0Z2dLX2J0YXNkZGFvQmxJdXZLSXotQVJnbWxUUlNUa2VsT29CblZOaC1mZnRKRWk2LWFmYS1ETGxlLThGV3p3Y2tRQTFjYVlLMDlKVXdiTUh3Unp4dVZRQlNkZHlXSnBMcmVVLUl2ZGc4TkZFNXZ2VmFnd2E1TXdwWTBQdFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "First Tracks Biotherapeutics (TRAX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9ueG1xXzljT2t2aTk3VHkwWjk3aExXVnIwaERLVnRkTlVMaF8talNCOENGUXdYekZ4Sjd3WGxjSDJXTThqVXc2M1RWN1ltSGpwYktn?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-20T14:15:33+00:00", "published_display": "20 Apr 2026 14:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AnaptysBio Completes Spinoff of First Tracks Biotherapeutics; Shares Surge", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/anaptysbio-completes-spinoff-first-tracks-135335110.html", "source_name": "MT Newswires", "published_at": "2026-04-20T13:53:35+00:00", "published_display": "20 Apr 2026 13:53", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TRAX Stock Price and Chart \u2014 NASDAQ:TRAX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE8tQkp2cFNVc1JNYzdYSWNmWG1Wc2E4RGRudW9VaFQ5MFlaNzlCSjBnNGZPYnR2ay03aWN4blBSMjU0R2Z5N0NLVWVwSEJvUjZPaXlFeUpRUUpKYVV4?oc=5", "source_name": "TradingView", "published_at": "2026-04-20T10:24:43+00:00", "published_display": "20 Apr 2026 10:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQTzdHYzVpTm5SLTBXNXdjY3c4b1NybnVRR29RR3VRTTF1c25sZDJreEd0UU5PV3BGcHNrVW1PakJCNkozOFJMdTRtZDluUTl1b3JwbXZZckszQ1V1XzE1c3IxX24wZjFfa1o2Z3cxRUVld2taNEJzU1dZdjZZSngxWkk3c1lvVmtsTzg4XzVIcS16dDBrb1ZSMW5fOFN1WFJQUUQzMTBOdFktZU02YjE3eQ?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Anaptys Completes Separation of First Tracks", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxOSVVzSzJNQ1Z2MV9Ia2NyaWVqeUl5SGZ5UktaM1Vnb05oSkprUTNwYjMxemZDd0hCS2lEeXNxcWFJV2YwQ3BPWGRPVG55blFQdE5NSk9CMHlmX3V0LXdDNFZCeFFMdk1hZHZZNTEyMllCaXpkUVhPSG5oZmE0VDRRa21hTnNTUTJyOXFjVXc2WkFueGhSeHJqaDhPN0pIeGY5WGw3dU9LMFE3b182VnQ1ODBfSkwtZjgtNWRwTkhnQkNOdWNUUlh0d25odW1jYUNHSlgzNU8yU3VoWmo5TXJpTG5hMDI1MzBjT1dXbmVZNkFXV1pqUllaSnpMWmtCeWNwZVZYM25PdDhXQlhhblkzUXFOTVlDbTJBeVpEZ3UzWkxmQ1JNakE?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics to be spun off from AnaptysBio, Nasdaq trading set for April 20", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPR09nY3hjc28yOVVsc3Z2aHNrU1hEMVdGaWtyRzQtTjg1WmJ4MXRsTzFiYkpwWjBydXkxczFrRGlzT0c5Mzh0Y0JFbnQ4b0x3UVk1OXFvdzVSdGlqYnM0WTZfSFZ6eFFNZzhJT2t4OURnUDZuOGs4REdVa1JmLXI5WGdKZkUyanUwM3Y2MGFzRFhHUWd1MkxISFFrdG9LcVpWaHo4Q195WVNJSmVoTG5UczI5ckVxZTR6WFQ0M3YzN2JGZzZIdzdpeU5TclVWNy1JdVRESXRESVhoc1E3VUswbQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ANAPTYSBIO (ANAB) reports ownership of 100 First Tracks Biotherapeutics shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPNTNMWld2cUthNlpNbmxWX0NjTjVJVmIxT0xUbGZkclBOWWlLTC1LRUpBUThLaGJjZ2ZnbEpNdF94Q2xYLUtuc3lFRU5mbnVhZ1NpN2NRUFhPcXpjWnBsV0Yxa0llOHVYaE9WVkdZNWxSS3dCSk0yNDNPaXpEZnMtUklUcEw3Z1dKTnl2MGtpOFBab1NWaEwzNkVjV3RRZTVFSHZUeXV0YTVsS3k4c3JHV1VMZ3pWNTJvaWszUTd0azJpeEk?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "First Tracks Biotherapeutics, the Planned Spin-Off of", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwJBVV95cUxNR1FMSFM3VHFDLUpoSTkzbjdTMU5obzhyUFFQWnU2aHZJYU1vV1dBcFFWUDdRbW5SUjdMMlZiRGQ3MHg4RUxqbDVHWE5fZWtBdnpudEVJMDJ0cFU1dHdIUUFKcG9BZ0U5bjRZeC1vVWxoNWRDRThZVmFlTTJSc2toWERKMF9BUElnNXRjemhwemMwTWt3VUlaOG9OTmhUWFlwLXZ2aHZhaUtIRnJDckRmclY0dHR2YXZJQlhraEttc0tKdHVJbGxIYVZzSjQ4V1M5UzgtNHljallseXBaeGdMS2tOc0FKMzBNeG5WRnIxRFBSQTcxeHZfMDlHMGllSF9MZXBnNGlrZ3FFVWcxUlkwZ09EaF9neXM?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics Secures $80 Million in Private Placement, Launching with $180 Million in Cash Post Spin-Off from AnaptysBio", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgJBVV95cUxNS3BUZ3Y2Q1RLM3FuZ2cyRTJqRUY4dEVLN2RseXdBMEFITW5fQlN2a0NTTWJyc08tMW05SlFpaTRkcXdjS29XenA0b2FJMU4wWTRTeWg2aHVXakhfMHVtTDY5OE50dHYwRjE1NktpNmdXUTBMNmZTem9Wbk1xT0NFamdGVURLS2h6ajJuLUw5UkswUTc0OFY5VHB2TGJTWFV1Q0dhbU1SdERWeDdTUThONTdFYXFWRi1KNGNnbWVVYlNlek5zV25iOTFGbngtSjc1bDd5SGFWM08zd0pUSzJZZmw5LWtfb2tBLV9WdEUxSkxkVThJVlN5T3Byd3V2aFAtaFpHUHR3?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks targets $180M cash at launch after $145M financing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNbm9YcHE3RWxUb1VuVnNUMkM0SHRVOWpIWXpZRGtTbktvQkpWbU03WWNVTVNoTTNHblZBU2xKLVp1WFl3RzF2YmtWa1NHZW03MTZIVktEbFpBZWgzUUlMdmRaR1RqV2I2enpoR3dQTVoyeDhNUDRYdGdYR2d5TVJuRlZQb0d6cGJRRzlWWkJjc2VZYmtpMUp0TmUyWURDMEtLbWRVenlMb2VUTVFONm9NYWhfUUtWXzFQMlUyRDlmSkY?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "First Tracks Biotherapeutics (TRAX) News Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwJBVV95cUxNbDJZcEdQN1VMWElpeEc5NExabExUaV9MNjEtQ1M3QnMzU2llOXlXVGlBTTZSVVpiM3l3cG5zRGhzZktOeVBVbHViSkRyeFhHNXM2WWNDaEU3S0tvUmxOOENJNXVRX2JuWEJBLUF6Z0dpWS1QLXlNLXRqaWNpMVBpTWh2Z2J6R3JLSkZDRlhrX0JXR3hKcUt4WFpfVUtPQ3k3a04wZko4Y1JGNFpCLXFMaE40MjJjR1ljSlNpaHZKUHF5NDAyTEcxTlo5SGlQNXp5dGo4X0I3Z2VkTDkxUUMzR3lJenlfenJ4QlFlUnJvRDkzYmNfUHB3UFV2eW43azVzZjlzVG5mSThmR3pZLWR6UmtyMmt6ZDNzeHVJcE83dw?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T04:56:01+00:00", "published_display": "13 Jul 2026 04:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $44", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNaUt6UFgyZkR3WDR3OFgxOWJvclFIYWlJMV9ILVJwR1FvdzV3X0VnU2JtMDFVWWlXU3JLREg0WmVIbmhiNjd4MkdLV3EwT2o4WFR4Q0pjaDFMcmhTUGgtVUw5dktsOTRzeFRoeXlWbUhQVDNYa1B2YVlhZDJkY0FadjdfSDZTdmprdE9pWHNTV3gtZjFtbWY4cGpjT3lkRzZ2MmcwRDJ4WXA5NElZRVhjRzBEVmM4SXc?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-10T16:36:12+00:00", "published_display": "10 Jul 2026 16:36", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9hM3JCNjBYQTdnVEhkZno5emZkTkt5Wk40TXNEVW5LM2VUR19rYkVpN2hZWGw0Uy1WZ29OR2RQUjZPN0hFYk9aaFQ0eV81QQ?oc=5", "source_name": "mexc.co", "published_at": "2026-07-10T14:18:03+00:00", "published_display": "10 Jul 2026 14:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics Inc. (TRAX) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE1YUmhkTHpNWl9CZE5BcHRYbEgtelJvbmllaWlucUF0V3Q2TDNpMnN5OGlwVmVMN0llaV9QaUlhNG81UkxnMkpXTm1SbHI5dw?oc=5", "source_name": "StocksToTrade", "published_at": "2026-07-10T00:43:00+00:00", "published_display": "10 Jul 2026 00:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (NASDAQ: TRAX) subleases 45,057 sq ft in San Diego", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQVWpuRmxJOWljekJKRTRvSmlLSVlTVUdoMFZDQ2RpSWtldzRtSzZ5aGhKYUp5QjYzRWxSaUdJTzR4dk9Pd1RjdzlFV1pKNVhrV3FlclZBM1ZUQzZOeEhkdnRIS2ljQ3FvM21RZzZFSXhUQUJ5dUh0cUQ1dTZWVnY5X1NIb1hQWnJha1hnYkFOSGI2YmVjVFlVZXhYNWJlQ1ViWTIwZHVqVlZENXBXSXpxTnUzbEtXbTMycWVPMkhR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rita Jain of First Tracks Biotherapeutics (TRAX) exercises RSUs, lifts holdings to 19,194 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQQXUwdVpSREZJY2JtaEFkQWtDUi00LTgtdWZGRHFxUEtacDBHbXFPaDdmMHZPanozRTNMQjFkTmNYdnpDaEk0bW9xTVhZSW56dFlyaGNIQ0hzRHlPUUpzWDRYLU91eVRCVm96a3dKQzhBa1k3dURqSUVDWlZxTEpJQ1RuOE1HUDg1YkFmcVh6RVgxbTVwUXVzYVZrd21VbnA3TlEtRWo3bFZjOWRSWUhNRDBDOWkzSkFSQW5IenFVazdlY1Iz?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (TRAX) director converts 6,030 RSUs into common stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOLXJ4eDFUVDcwMjdLVDg1elNsNU50WlZyUVZ6TWR6YjBrbHZ2dmV6ZXppRlczdXdtaGE0dzBBOUdDRmxkUGNfT2pWSG96ZG40RldDSHYyYjhGQWtoZTNnS19QTHNEYWhnSjR1V2NWVEMyZ1ctcVVBUEZ3dlVGVlVXMXVLb1l4djNxOGxrV2Q1V2d5NURURXJDSUxhamFRTzdJd0kwMFh3WEJZUGlscmhBNkUyNTgwdEo2ZUJkQWg4UWp1d2l3?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/first-tracks-biotherapeutics-announces-participation-201500599.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T20:15:00+00:00", "published_display": "21 May 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/first-tracks-biotherapeutics-announces-first-201500695.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T20:15:00+00:00", "published_display": "14 May 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://finance.yahoo.com/news/anaptys-announces-first-quarter-2026-201500897.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T20:15:00+00:00", "published_display": "12 May 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piper Sandler Initiates Coverage on First Tracks Biotherapeutics With Overweight Rating, $54 Price Target", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/piper-sandler-initiates-coverage-first-121857533.html", "source_name": "MT Newswires", "published_at": "2026-05-04T12:18:57+00:00", "published_display": "04 May 2026 12:18", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (TRAX) Stock Trends and Sentiment 2026 $TRAX", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTFAtRFVUejdTMTA0anlfVThnUW10Rk5wZWVUSXZ6UmNkZUVkNFRwekx1ZHE2Y05FdVhuc1VjSmxhN095ZzRCYUFYX1FtZVZrRlk3QVZETVRWV3ZnNjdLRmFCX3pmblM3YXI3dFVrTUlISVFKRngxRVE?oc=5", "source_name": "MarketBeat", "published_at": "2026-04-21T16:08:34+00:00", "published_display": "21 Apr 2026 16:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (TRAX) Stock Forecast and Price Target 2026 $TRAX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5UTUtSME9MWWNreXFja0VtTHhySFdYMk1RSTNhVTBnWldqVFVkcmNESGp3akE2WEhrS01VbHlnT2JZZU5NRkV0TXJ0b2l4OUM1THQwT21hdjRXRmpQYnNJbVREQkRYZw?oc=5", "source_name": "MarketBeat", "published_at": "2026-04-21T15:42:34+00:00", "published_display": "21 Apr 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (TRAX) Stock Price, News & Analysis $TRAX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE90bzE4eUNTRExvenNKMTRWX2FNMVBvWmxGODJtdkpjSGthMXF2WnJjUWh6NmlpaXlLUE5tWFFTNTJZQlR6dXBJUlBMRWpkTDc5WVBNWXZ0SzBxUQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-04-21T14:18:23+00:00", "published_display": "21 Apr 2026 14:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (TRAX) Stock Chart and Price History 2026 $TRAX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE1XS3U0eWZlcUhYXzNHNU1tQ013SEt3Q0RfUlVld0F4MUo3QnhrdUlkUEwyaW1nc2MxSTZsV1ZsNzl1OTdqN0NYZnQ3SHk1TVo0X1JUZjltOFpVbnNzR29PRjVR?oc=5", "source_name": "MarketBeat", "published_at": "2026-04-21T14:16:10+00:00", "published_display": "21 Apr 2026 14:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics (ANAB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPWEhVM1c0S09lTUNwU2l0ZVFFS2VTY2FiUWJoNVp1MXFRV0JZZkxUZHZYR0FOMV84TUx0Z2dLX2J0YXNkZGFvQmxJdXZLSXotQVJnbWxUUlNUa2VsT29CblZOaC1mZnRKRWk2LWFmYS1ETGxlLThGV3p3Y2tRQTFjYVlLMDlKVXdiTUh3Unp4dVZRQlNkZHlXSnBMcmVVLUl2ZGc4TkZFNXZ2VmFnd2E1TXdwWTBQdFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics (TRAX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9ueG1xXzljT2t2aTk3VHkwWjk3aExXVnIwaERLVnRkTlVMaF8talNCOENGUXdYekZ4Sjd3WGxjSDJXTThqVXc2M1RWN1ltSGpwYktn?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-20T14:15:33+00:00", "published_display": "20 Apr 2026 14:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AnaptysBio Completes Spinoff of First Tracks Biotherapeutics; Shares Surge", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/anaptysbio-completes-spinoff-first-tracks-135335110.html", "source_name": "MT Newswires", "published_at": "2026-04-20T13:53:35+00:00", "published_display": "20 Apr 2026 13:53", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TRAX Stock Price and Chart \u2014 NASDAQ:TRAX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE8tQkp2cFNVc1JNYzdYSWNmWG1Wc2E4RGRudW9VaFQ5MFlaNzlCSjBnNGZPYnR2ay03aWN4blBSMjU0R2Z5N0NLVWVwSEJvUjZPaXlFeUpRUUpKYVV4?oc=5", "source_name": "TradingView", "published_at": "2026-04-20T10:24:43+00:00", "published_display": "20 Apr 2026 10:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQTzdHYzVpTm5SLTBXNXdjY3c4b1NybnVRR29RR3VRTTF1c25sZDJreEd0UU5PV3BGcHNrVW1PakJCNkozOFJMdTRtZDluUTl1b3JwbXZZckszQ1V1XzE1c3IxX24wZjFfa1o2Z3cxRUVld2taNEJzU1dZdjZZSngxWkk3c1lvVmtsTzg4XzVIcS16dDBrb1ZSMW5fOFN1WFJQUUQzMTBOdFktZU02YjE3eQ?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Anaptys Completes Separation of First Tracks", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxOSVVzSzJNQ1Z2MV9Ia2NyaWVqeUl5SGZ5UktaM1Vnb05oSkprUTNwYjMxemZDd0hCS2lEeXNxcWFJV2YwQ3BPWGRPVG55blFQdE5NSk9CMHlmX3V0LXdDNFZCeFFMdk1hZHZZNTEyMllCaXpkUVhPSG5oZmE0VDRRa21hTnNTUTJyOXFjVXc2WkFueGhSeHJqaDhPN0pIeGY5WGw3dU9LMFE3b182VnQ1ODBfSkwtZjgtNWRwTkhnQkNOdWNUUlh0d25odW1jYUNHSlgzNU8yU3VoWmo5TXJpTG5hMDI1MzBjT1dXbmVZNkFXV1pqUllaSnpMWmtCeWNwZVZYM25PdDhXQlhhblkzUXFOTVlDbTJBeVpEZ3UzWkxmQ1JNakE?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics to be spun off from AnaptysBio, Nasdaq trading set for April 20", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPR09nY3hjc28yOVVsc3Z2aHNrU1hEMVdGaWtyRzQtTjg1WmJ4MXRsTzFiYkpwWjBydXkxczFrRGlzT0c5Mzh0Y0JFbnQ4b0x3UVk1OXFvdzVSdGlqYnM0WTZfSFZ6eFFNZzhJT2t4OURnUDZuOGs4REdVa1JmLXI5WGdKZkUyanUwM3Y2MGFzRFhHUWd1MkxISFFrdG9LcVpWaHo4Q195WVNJSmVoTG5UczI5ckVxZTR6WFQ0M3YzN2JGZzZIdzdpeU5TclVWNy1JdVRESXRESVhoc1E3VUswbQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ANAPTYSBIO (ANAB) reports ownership of 100 First Tracks Biotherapeutics shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPNTNMWld2cUthNlpNbmxWX0NjTjVJVmIxT0xUbGZkclBOWWlLTC1LRUpBUThLaGJjZ2ZnbEpNdF94Q2xYLUtuc3lFRU5mbnVhZ1NpN2NRUFhPcXpjWnBsV0Yxa0llOHVYaE9WVkdZNWxSS3dCSk0yNDNPaXpEZnMtUklUcEw3Z1dKTnl2MGtpOFBab1NWaEwzNkVjV3RRZTVFSHZUeXV0YTVsS3k4c3JHV1VMZ3pWNTJvaWszUTd0azJpeEk?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics, the Planned Spin-Off of", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwJBVV95cUxNR1FMSFM3VHFDLUpoSTkzbjdTMU5obzhyUFFQWnU2aHZJYU1vV1dBcFFWUDdRbW5SUjdMMlZiRGQ3MHg4RUxqbDVHWE5fZWtBdnpudEVJMDJ0cFU1dHdIUUFKcG9BZ0U5bjRZeC1vVWxoNWRDRThZVmFlTTJSc2toWERKMF9BUElnNXRjemhwemMwTWt3VUlaOG9OTmhUWFlwLXZ2aHZhaUtIRnJDckRmclY0dHR2YXZJQlhraEttc0tKdHVJbGxIYVZzSjQ4V1M5UzgtNHljallseXBaeGdMS2tOc0FKMzBNeG5WRnIxRFBSQTcxeHZfMDlHMGllSF9MZXBnNGlrZ3FFVWcxUlkwZ09EaF9neXM?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks Biotherapeutics Secures $80 Million in Private Placement, Launching with $180 Million in Cash Post Spin-Off from AnaptysBio", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgJBVV95cUxNS3BUZ3Y2Q1RLM3FuZ2cyRTJqRUY4dEVLN2RseXdBMEFITW5fQlN2a0NTTWJyc08tMW05SlFpaTRkcXdjS29XenA0b2FJMU4wWTRTeWg2aHVXakhfMHVtTDY5OE50dHYwRjE1NktpNmdXUTBMNmZTem9Wbk1xT0NFamdGVURLS2h6ajJuLUw5UkswUTc0OFY5VHB2TGJTWFV1Q0dhbU1SdERWeDdTUThONTdFYXFWRi1KNGNnbWVVYlNlek5zV25iOTFGbngtSjc1bDd5SGFWM08zd0pUSzJZZmw5LWtfb2tBLV9WdEUxSkxkVThJVlN5T3Byd3V2aFAtaFpHUHR3?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Tracks targets $180M cash at launch after $145M financing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNbm9YcHE3RWxUb1VuVnNUMkM0SHRVOWpIWXpZRGtTbktvQkpWbU03WWNVTVNoTTNHblZBU2xKLVp1WFl3RzF2YmtWa1NHZW03MTZIVktEbFpBZWgzUUlMdmRaR1RqV2I2enpoR3dQTVoyeDhNUDRYdGdYR2d5TVJuRlZQb0d6cGJRRzlWWkJjc2VZYmtpMUp0TmUyWURDMEtLbWRVenlMb2VUTVFONm9NYWhfUUtWXzFQMlUyRDlmSkY?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 81, "total_relevant": 34, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 29, "score": 52, "total": 34, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 10.8, "count": 19}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 10}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 36.24, "latest_week": "2026-07-10", "one_week_move": 87.8, "four_week_move": 105.4, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": 86.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 47.1311, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+87.8% over one week, +105.4% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 6}, {"label": "Stock Titan", "count": 6}, {"label": "GlobeNewswire", "count": 5}, {"label": "MarketBeat", "count": 4}, {"label": "simplywall.st", "count": 2}, {"label": "MT Newswires", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "Moomoo", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 26}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 19}, {"label": "Earnings", "count": 10}, {"label": "Analyst action", "count": 2}, {"label": "Balance sheet", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "26", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+87.8% over one week, +105.4% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "First Tracks Biotherapeutics (TRAX) News Flow"}], "updated_at": "2026-07-16T00:45:33.606122+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}